These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28036290)

  • 1. Yes-associated protein 1 promotes papillary thyroid cancer cell proliferation by activating the ERK/MAPK signaling pathway.
    Liao T; Wen D; Ma B; Hu JQ; Qu N; Shi RL; Liu L; Guan Q; Li DS; Ji QH
    Oncotarget; 2017 Feb; 8(7):11719-11728. PubMed ID: 28036290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.
    Yu ST; Zhong Q; Chen RH; Han P; Li SB; Zhang H; Yuan L; Xia TL; Zeng MS; Huang XM
    Cell Death Dis; 2018 Mar; 9(3):371. PubMed ID: 29515111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Lu J; Chen GQ; Zheng YL
    Cell Death Dis; 2018 Sep; 9(10):947. PubMed ID: 30237435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
    Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
    Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DLG1-AS1/miR-497/YAP1 axis regulates papillary thyroid cancer progression.
    Huang Y; Zhang K; Li Y; Dai Y; Zhao H
    Aging (Albany NY); 2020 Nov; 12(22):23326-23336. PubMed ID: 33197895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
    Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
    J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of ANXA10 inhibits proliferation and promotes apoptosis of papillary thyroid carcinoma cells by down-regulating TSG101 thereby inactivating the MAPK/ERK signaling pathway.
    Wei T; Zhu X
    J Bioenerg Biomembr; 2021 Aug; 53(4):429-440. PubMed ID: 34032966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.
    Wen D; Liao T; Ma B; Qu N; Shi RL; Lu ZW; Wang YL; Wei WJ; Ji QH
    Cancer Med; 2018 Feb; 7(2):285-296. PubMed ID: 29341469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
    Wang Y; Liu BG; Zhou CX
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
    Fan C; Wang W; Jin J; Yu Z; Xin X
    Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
    Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J
    J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-506-3p suppresses papillary thyroid cancer cells tumorigenesis by targeting YAP1.
    Chen L; Wang X; Ji C; Hu J; Fang L
    Pathol Res Pract; 2020 Dec; 216(12):153231. PubMed ID: 33059240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway.
    Wang Y; Lin X; Fu X; Yan W; Lin F; Kuang P; Luo Y; Lin E; Hong X; Wu G
    Oncol Rep; 2018 Aug; 40(2):859-866. PubMed ID: 29917164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR‑205 targets YAP1 and inhibits proliferation and invasion in thyroid cancer cells.
    Li D; Wang Q; Li N; Zhang S
    Mol Med Rep; 2018 Aug; 18(2):1674-1681. PubMed ID: 29845281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
    Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
    J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAM172A protein promotes the proliferation of human papillary thyroid carcinoma cells via the p38 mitogen-activated protein kinase pathway.
    Li MF; Zhang R; Guo MG; Li LX; Lu HK; Lu JX; Jia WP
    Mol Med Rep; 2016 Jan; 13(1):353-8. PubMed ID: 26573560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1.
    Han J; Zhang M; Nie C; Jia J; Wang F; Yu J; Bi W; Liu B; Sheng R; He G; Kong L; Zheng L; Pang R; Ding Z; Chen L; Guan Q; Pan S; Meng X; Xu J; Liu L; Zhang J
    Cell Death Dis; 2019 Feb; 10(3):195. PubMed ID: 30814512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma.
    Luo D; Liu Y; Lin S; Tan L; Du Z; Long M; Zhu Y; Peng X; Zong W; Mackenzie GG; Li H; Ouyang N
    Oncol Rep; 2019 Feb; 41(2):1253-1263. PubMed ID: 30535496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated siRNA targeting NOB1 inhibits tumor growth and enhances radiosensitivity of human papillary thyroid carcinoma in vitro and in vivo.
    Meng W; Wang PS; Liu J; Xue S; Wang GM; Meng XY; Chen G
    Oncol Rep; 2014 Dec; 32(6):2411-20. PubMed ID: 25231838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.